{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:31:15Z","timestamp":1792801875016,"version":"4.5.0"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-025-01661-y","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:17:07Z","timestamp":1767770227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dual-Targeting miR-219 and miR-146a in Multiple Sclerosis: Bridging Myelin Repair and Neuroinflammation for Novel Therapeutic Insights"],"prefix":"10.1007","volume":"46","author":[{"given":"Abdullah","family":"Yadegari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Tahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira Roshani","family":"Asl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Vahidinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Barati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"issue":"3\u20134","key":"1661_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1101\/gad.344218.120","volume":"35","author":"LA Akay","year":"2021","unstructured":"Akay LA, Effenberger AH, Tsai L-H (2021) Cell of all trades: oligodendrocyte precursor cells in synaptic, vascular, and immune function. Genes Dev 35(3\u20134):180\u2013198","journal-title":"Genes Dev"},{"key":"1661_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32685","author":"R Al-Temaimi","year":"2024","unstructured":"Al-Temaimi R, Alroughani R (2024) MiR-24-3p and miR-484 are potential biomarkers for neurodegeneration in multiple sclerosis. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32685","journal-title":"Heliyon"},{"key":"1661_CR3","doi-asserted-by":"publisher","DOI":"10.17226\/23592","volume-title":"Relevance of Health Literacy to Precision Medicine: Proceedings of a Workshop","author":"J Alper","year":"2016","unstructured":"Alper J (2016) Relevance of Health Literacy to Precision Medicine: Proceedings of a Workshop. National Academies Press"},{"issue":"1","key":"1661_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2217\/nmt-2021-0058","volume":"13","author":"M Amin","year":"2023","unstructured":"Amin M, Hersh CM (2023) Updates and advances in multiple sclerosis neurotherapeutics. Neurodegener Dis Manage 13(1):47\u201370","journal-title":"Neurodegener Dis Manage"},{"issue":"1","key":"1661_CR5","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1038\/s41598-020-63282-3","volume":"10","author":"A Amoruso","year":"2020","unstructured":"Amoruso A, Blonda M, Gironi M, Grasso R, Di Francescantonio V, Scaroni F et al (2020) Immune and central nervous system-related MiRNAs expression profiling in monocytes of multiple sclerosis patients. Sci Rep 10(1):6125","journal-title":"Sci Rep"},{"key":"1661_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2021.07.004","volume":"238","author":"M Aslani","year":"2021","unstructured":"Aslani M, Mortazavi-Jahromi SS, Mirshafiey A (2021) Efficient roles of miR-146a in cellular and molecular mechanisms of neuroinflammatory disorders: an effectual review in neuroimmunology. Immunol Lett 238:1\u201320","journal-title":"Immunol Lett"},{"issue":"11","key":"1661_CR7","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","volume":"20","author":"MM Attwood","year":"2021","unstructured":"Attwood MM, Fabbro D, Sokolov AV, Knapp S, Schi\u00f6th HB (2021) Trends in kinase drug discovery: targets, indications and inhibitor design. Nat Rev Drug Discov 20(11):839\u2013861","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"1661_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41593-020-0637-3","volume":"23","author":"CM Bacmeister","year":"2020","unstructured":"Bacmeister CM, Barr HJ, McClain CR, Thornton MA, Nettles D, Welle CG et al (2020) Motor learning promotes remyelination via new and surviving oligodendrocytes. Nat Neurosci 23(7):819\u2013831","journal-title":"Nat Neurosci"},{"issue":"6","key":"1661_CR9","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nn.3109","volume":"15","author":"L Bai","year":"2012","unstructured":"Bai L, Lennon DP, Caplan AI, DeChant A, Hecker J, Kranso J et al (2012) Hepatocyte growth factor mediates mesenchymal stem cell\u2013induced recovery in multiple sclerosis models. Nat Neurosci 15(6):862\u2013870","journal-title":"Nat Neurosci"},{"issue":"1","key":"1661_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel DP (2018) Metazoan Micrornas. Cell 173(1):20\u201351","journal-title":"Cell"},{"key":"1661_CR11","doi-asserted-by":"publisher","first-page":"1492678","DOI":"10.3389\/fneur.2024.1492678","volume":"15","author":"M Bayounis","year":"2024","unstructured":"Bayounis M, Bin Mahfooz M, Assiri M, Alghamdi Y, Alturki F, Almutairi M et al (2024) Risk of malignancy and the use of disease-modifying therapy in multiple sclerosis: exploring the role of DMT in a multi-center study. Front Neurol 15:1492678","journal-title":"Front Neurol"},{"issue":"1","key":"1661_CR12","doi-asserted-by":"publisher","first-page":"12921","DOI":"10.1038\/s41598-022-17081-7","volume":"12","author":"RM Beiter","year":"2022","unstructured":"Beiter RM, Rivet-Noor C, Merchak AR, Bai R, Johanson DM, Slogar E et al (2022) Evidence for oligodendrocyte progenitor cell heterogeneity in the adult mouse brain. Sci Rep 12(1):12921","journal-title":"Sci Rep"},{"issue":"2","key":"1661_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a020453","volume":"8","author":"DE Bergles","year":"2015","unstructured":"Bergles DE, Richardson WD (2015) Oligodendrocyte development and plasticity. Cold Spring Harb Perspect Biol 8(2):a020453","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1661_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11064-010-0252-x","volume":"36","author":"HO Besedovsky","year":"2011","unstructured":"Besedovsky HO, Del Rey A (2011) Central and peripheral cytokines mediate immune-brain connectivity. Neurochem Res 36:1\u20136","journal-title":"Neurochem Res"},{"issue":"5","key":"1661_CR15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.24620","volume":"79","author":"B Bodini","year":"2016","unstructured":"Bodini B, Veronese M, Garc\u00eda-Lorenzo D, Battaglini M, Poirion E, Chardain A et al (2016) Dynamic imaging of individual remyelination profiles in multiple sclerosis. Ann Neurol 79(5):726\u2013738","journal-title":"Ann Neurol"},{"issue":"6","key":"1661_CR16","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1084\/jem.20101823","volume":"208","author":"MP Boldin","year":"2011","unstructured":"Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M et al (2011) miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 208(6):1189","journal-title":"J Exp Med"},{"issue":"3","key":"1661_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11302-012-9305-8","volume":"8","author":"M Bonora","year":"2012","unstructured":"Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, Bononi A et al (2012) ATP synthesis and storage. Purinergic Signal 8(3):343\u2013357","journal-title":"Purinergic Signal"},{"issue":"4","key":"1661_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3390\/biom10040589","volume":"10","author":"M Bottani","year":"2020","unstructured":"Bottani M, Banfi G, Lombardi G (2020) The clinical potential of circulating miRNAs as biomarkers: present and future applications for diagnosis and prognosis of age-associated bone diseases. Biomolecules 10(4):589","journal-title":"Biomolecules"},{"issue":"9","key":"1661_CR19","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1093\/brain\/awr199","volume":"134","author":"R Brambilla","year":"2011","unstructured":"Brambilla R, Ashbaugh JJ, Magliozzi R, Dellarole A, Karmally S, Szymkowski DE et al (2011) Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination. Brain 134(9):2736\u20132754","journal-title":"Brain"},{"issue":"10","key":"1661_CR20","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1093\/brain\/awq250","volume":"133","author":"S Bramow","year":"2010","unstructured":"Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, S\u00f8rensen PS et al (2010) Demyelination versus remyelination in progressive multiple sclerosis. Brain 133(10):2983\u20132998","journal-title":"Brain"},{"issue":"3","key":"1661_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s13346-015-0220-8","volume":"5","author":"M-L Briuglia","year":"2015","unstructured":"Briuglia M-L, Rotella C, McFarlane A, Lamprou DA (2015) Influence of cholesterol on liposome stability and on in vitro drug release. Drug Deliv Transl Res 5(3):231\u2013242","journal-title":"Drug Deliv Transl Res"},{"issue":"2","key":"1661_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1001\/jama.2018.20588","volume":"321","author":"JWL Brown","year":"2019","unstructured":"Brown JWL, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A et al (2019) Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis. JAMA 321(2):175\u2013187","journal-title":"JAMA"},{"issue":"1","key":"1661_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-1006-3","volume":"14","author":"IB Bruinsma","year":"2017","unstructured":"Bruinsma IB, van Dijk M, Bridel C, van de Lisdonk T, Haverkort SQ, Runia TF et al (2017) Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS. J Neuroinflammation 14(1):235","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1661_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1474-4422(16)30377-5","volume":"16","author":"D Cadavid","year":"2017","unstructured":"Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch L et al (2017) Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. Lancet Neurol 16(3):189\u201399","journal-title":"Lancet Neurol"},{"issue":"9","key":"1661_CR25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S1474-4422(19)30137-1","volume":"18","author":"D Cadavid","year":"2019","unstructured":"Cadavid D, Mellion M, Hupperts R, Edwards KR, Calabresi PA, Drulovi\u0107 J et al (2019) Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial. Lancet Neurol 18(9):845\u2013856","journal-title":"Lancet Neurol"},{"issue":"7","key":"1661_CR26","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/genes14071375","volume":"14","author":"A Chakrabortty","year":"2023","unstructured":"Chakrabortty A, Patton DJ, Smith BF, Agarwal P (2023) MiRNAs: potential as biomarkers and therapeutic targets for cancer. Genes 14(7):1375","journal-title":"Genes"},{"key":"1661_CR27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.neuropharm.2015.10.010","volume":"110","author":"KA Chamberlain","year":"2016","unstructured":"Chamberlain KA, Nanescu SE, Psachoulia K, Huang JK (2016) Oligodendrocyte regeneration: its significance in myelin replacement and neuroprotection in multiple sclerosis. Neuropharmacology 110:633\u2013643","journal-title":"Neuropharmacology"},{"key":"1661_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116829","volume":"235","author":"X Chen","year":"2019","unstructured":"Chen X, Tan X-R, Li S-J, Zhang X-X (2019) LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p\/ROCK1 in nonalcoholic fatty liver disease. Life Sci 235:116829","journal-title":"Life Sci"},{"issue":"12","key":"1661_CR29","doi-asserted-by":"publisher","first-page":"e0189380","DOI":"10.1371\/journal.pone.0189380","volume":"12","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zhen W, Guo T, Zhao Y, Liu A, Rubio JP et al (2017) Histamine receptor 3 negatively regulates oligodendrocyte differentiation and remyelination. PLoS One 12(12):e0189380","journal-title":"PLoS One"},{"issue":"1","key":"1661_CR30","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1038\/s41467-018-05196-3","volume":"9","author":"S Cho","year":"2018","unstructured":"Cho S, Lee H-M, Yu I-S, Choi YS, Huang H-Y, Hashemifar SS et al (2018) Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b. Nat Commun 9(1):2757","journal-title":"Nat Commun"},{"issue":"3","key":"1661_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/10408444.2021.1907530","volume":"51","author":"BN Chorley","year":"2021","unstructured":"Chorley BN, Atabakhsh E, Doran G, Gautier J-C, Ellinger-Ziegelbauer H, Jackson D et al (2021) Methodological considerations for measuring biofluid-based microRNA biomarkers. Crit Rev Toxicol 51(3):264\u201382","journal-title":"Crit Rev Toxicol"},{"issue":"13","key":"1661_CR32","doi-asserted-by":"publisher","first-page":"e1280","DOI":"10.1212\/WNL.0000000000207664","volume":"101","author":"A Cobo-Calvo","year":"2023","unstructured":"Cobo-Calvo A, Tur C, Otero-Romero S, Carbonell-Mirabent P, Ruiz M, Pappolla A et al (2023) Association of very early treatment initiation with the risk of long-term disability in patients with a first demyelinating event. Neurology 101(13):e1280\u2013e92","journal-title":"Neurology"},{"issue":"1","key":"1661_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ana.25927","volume":"89","author":"G Comi","year":"2021","unstructured":"Comi G, Bar-Or A, Lassmann H, Uccelli A, Hartung HP, Montalban X et al (2021) Role of B cells in multiple sclerosis and related disorders. Ann Neurol 89(1):13\u201323","journal-title":"Ann Neurol"},{"issue":"20","key":"1661_CR34","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/NEJM200011163432001","volume":"343","author":"C Confavreux","year":"2000","unstructured":"Confavreux C, Vukusic S, Moreau T, Adeleine P (2000) Relapses and progression of disability in multiple sclerosis. N Engl J Med 343(20):1430\u20131438","journal-title":"N Engl J Med"},{"issue":"1","key":"1661_CR35","first-page":"1872593","volume":"2019","author":"A Cramer","year":"2019","unstructured":"Cramer A, de Lima Oliveira BC, Leite PG, Rodrigues DH, Brant F, Esper L et al (2019) Role of SOCS2 in the regulation of immune response and development of the experimental autoimmune encephalomyelitis. Mediat Inflamm 2019(1):1872593","journal-title":"Mediat Inflamm"},{"issue":"4","key":"1661_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ana.24747","volume":"80","author":"B Cree","year":"2016","unstructured":"Cree B, Gourraud P, Oksenberg J, Bevan C, Crabtree-Hartman E, Gelfand J, University of California, San Francisco MS-EPIC Team (2016) Long-term evolution of multiple sclerosis disability in the treatment era. Ann Neurol 80(4):499\u2013510","journal-title":"Ann Neurol"},{"issue":"5","key":"1661_CR37","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1084\/jem.20091419","volume":"207","author":"NC Derecki","year":"2010","unstructured":"Derecki NC, Cardani AN, Yang CH, Quinnies KM, Crihfield A, Lynch KR et al (2010) Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med 207(5):1067\u201380","journal-title":"J Exp Med"},{"issue":"11","key":"1661_CR38","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2015.09.002","volume":"31","author":"T Desvignes","year":"2015","unstructured":"Desvignes T, Batzel P, Berezikov E, Eilbeck K, Eppig JT, McAndrews MS et al (2015) miRNA nomenclature: a view incorporating genetic origins, biosynthetic pathways, and sequence variants. Trends Genet 31(11):613\u201326","journal-title":"Trends Genet"},{"issue":"12","key":"1661_CR39","doi-asserted-by":"publisher","first-page":"5750","DOI":"10.4049\/jimmunol.1500615","volume":"195","author":"C Doxaki","year":"2015","unstructured":"Doxaki C, Kampranis SC, Eliopoulos AG, Spilianakis C, Tsatsanis C (2015) Coordinated regulation of miR-155 and miR-146a genes during induction of endotoxin tolerance in macrophages. J Immunol 195(12):5750\u20135761","journal-title":"J Immunol"},{"issue":"7","key":"1661_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071711","volume":"9","author":"CP Duffy","year":"2020","unstructured":"Duffy CP, McCoy CE (2020) The role of MicroRNAs in repair processes in multiple sclerosis. Cells 9(7):1711","journal-title":"Cells"},{"issue":"5","key":"1661_CR41","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.neuron.2010.01.027","volume":"65","author":"JC Dugas","year":"2010","unstructured":"Dugas JC, Cuellar TL, Scholze A, Ason B, Ibrahim A, Emery B et al (2010) Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 65(5):597\u2013611","journal-title":"Neuron"},{"issue":"3","key":"1661_CR42","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00401-017-1741-7","volume":"134","author":"GJ Duncan","year":"2017","unstructured":"Duncan GJ, Plemel JR, Assinck P, Manesh SB, Muir FGW, Hirata R et al (2017) Myelin regulatory factor drives remyelination in multiple sclerosis. Acta Neuropathol 134(3):403\u2013422","journal-title":"Acta Neuropathol"},{"issue":"16","key":"1661_CR43","doi-asserted-by":"publisher","first-page":"6832","DOI":"10.1073\/pnas.0812500106","volume":"106","author":"I Duncan","year":"2009","unstructured":"Duncan I, Brower A, Kondo Y, Curlee J Jr, Schultz R (2009) Extensive remyelination of the CNS leads to functional recovery. Proc Natl Acad Sci 106(16):6832\u20136836","journal-title":"Proc Natl Acad Sci"},{"key":"1661_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101680","author":"F Fagiani","year":"2024","unstructured":"Fagiani F, Pedrini E, Taverna S, Brambilla E, Murtaj V, Podini P et al (2024) A glia-enriched stem cell 3D model of the human brain mimics the glial-immune neurodegenerative phenotypes of multiple sclerosis. Cell Rep Med. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101680","journal-title":"Cell Rep Med"},{"issue":"12","key":"1661_CR45","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1038\/s41591-018-0236-y","volume":"24","author":"AM Falc\u00e3o","year":"2018","unstructured":"Falc\u00e3o AM, van Bruggen D, Marques S, Meijer M, J\u00e4kel S, Agirre E et al (2018) Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nat Med 24(12):1837\u20131844","journal-title":"Nat Med"},{"key":"1661_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114593","volume":"162","author":"J Fan","year":"2023","unstructured":"Fan J, Han Y, Sun H, Sun S, Wang Y, Guo R et al (2023) Mesenchymal stem cell-derived exosomal microRNA-367\u20133p alleviates experimental autoimmune encephalomyelitis via inhibition of microglial ferroptosis by targeting EZH2. Biomed Pharmacother 162:114593","journal-title":"Biomed Pharmacother"},{"key":"1661_CR47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fnmol.2020.00090","volume":"13","author":"W Fan","year":"2020","unstructured":"Fan W, Liang C, Ou M, Zou T, Sun F, Zhou H et al (2020) MicroRNA-146a is a wide-reaching neuroinflammatory regulator and potential treatment target in neurological diseases. Front Mol Neurosci 13:90","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"1661_CR48","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3390\/ijms21020561","volume":"21","author":"K Felekkis","year":"2020","unstructured":"Felekkis K, Papaneophytou C (2020) Challenges in using circulating micro-RNAs as biomarkers for cardiovascular diseases. Int J Mol Sci 21(2):561","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1661_CR49","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/iub.2575","volume":"73","author":"K Felekkis","year":"2021","unstructured":"Felekkis K, Pieri M, Papaneophytou C (2021) Variability in the levels of exosomal miRNAs among human subjects could be explained by differential interactions of exosomes with the endothelium. IUBMB Life 73(12):1400\u20131405","journal-title":"IUBMB Life"},{"issue":"17","key":"1661_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713144","volume":"24","author":"K Felekkis","year":"2023","unstructured":"Felekkis K, Pieri M, Papaneophytou C (2023) Exploring the feasibility of circulating miRNAs as diagnostic and prognostic biomarkers in osteoarthritis: challenges and opportunities. Int J Mol Sci 24(17):13144","journal-title":"Int J Mol Sci"},{"key":"1661_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.01.005","volume":"57","author":"A Fernandez-Castaneda","year":"2016","unstructured":"Fernandez-Castaneda A, Gaultier A (2016) Adult oligodendrocyte progenitor cells\u2013multifaceted regulators of the CNS in health and disease. Brain Behav Immun 57:1\u20137","journal-title":"Brain Behav Immun"},{"key":"1661_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2022.100129","volume":"3","author":"EG Figueroa","year":"2022","unstructured":"Figueroa EG, Caballero-Rom\u00e1n A, Tic\u00f3 JR, Mi\u00f1arro M, Nardi-Ricart A, Gonz\u00e1lez-Candia A (2022) miRNA nanoencapsulation to regulate the programming of the blood-brain barrier permeability by hypoxia. Curr Res Pharmacol Drug Discov 3:100129","journal-title":"Curr Res Pharmacol Drug Discov"},{"issue":"10","key":"1661_CR53","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3390\/brainsci10100758","volume":"10","author":"D Florou","year":"2020","unstructured":"Florou D, Katsara M, Feehan J, Dardiotis E, Apostolopoulos V (2020) Anti-CD20 agents for multiple sclerosis: spotlight on Ocrelizumab and ofatumumab. Brain Sci 10(10):758","journal-title":"Brain Sci"},{"issue":"4","key":"1661_CR54","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/jamaneurol.2017.4850","volume":"75","author":"RJ Fox","year":"2018","unstructured":"Fox RJ (2018) Tissue markers for acute multiple sclerosis treatment response\u2014a step toward personalized medicine. JAMA Neurol 75(4):406\u2013407","journal-title":"JAMA Neurol"},{"issue":"12","key":"1661_CR55","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nrn.2017.136","volume":"18","author":"RJ Franklin","year":"2017","unstructured":"Franklin RJ, Ffrench-Constant C (2017) Regenerating CNS myelin\u2014from mechanisms to experimental medicines. Nat Rev Neurosci 18(12):753\u2013769","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"1661_CR56","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/glia.22622","volume":"62","author":"RJ Franklin","year":"2014","unstructured":"Franklin RJ, Gallo V (2014) The translational biology of remyelination: past, present, and future. Glia 62(11):1905\u20131915","journal-title":"Glia"},{"issue":"7","key":"1661_CR57","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a020594","volume":"7","author":"RJ Franklin","year":"2015","unstructured":"Franklin RJ, Goldman SA (2015) Glia disease and repair\u2014remyelination. Cold Spring Harb Perspect Biol 7(7):a020594","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"1661_CR58","doi-asserted-by":"publisher","first-page":"34512","DOI":"10.1038\/srep34512","volume":"6","author":"S Freiesleben","year":"2016","unstructured":"Freiesleben S, Hecker M, Zettl UK, Fuellen G, Taher L (2016) Analysis of MicroRNA and gene expression profiles in multiple sclerosis: integrating interaction data to uncover regulatory mechanisms. Sci Rep 6(1):34512","journal-title":"Sci Rep"},{"issue":"9","key":"1661_CR59","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1056\/NEJMra052130","volume":"354","author":"EM Frohman","year":"2006","unstructured":"Frohman EM, Racke MK, Raine CS (2006) Multiple sclerosis\u2014the plaque and its pathogenesis. N Engl J Med 354(9):942\u2013955","journal-title":"N Engl J Med"},{"issue":"7399","key":"1661_CR60","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature11007","volume":"485","author":"U F\u00fcnfschilling","year":"2012","unstructured":"F\u00fcnfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J et al (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485(7399):517\u2013521","journal-title":"Nature"},{"issue":"2","key":"1661_CR61","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.neuron.2014.06.010","volume":"83","author":"V Gallo","year":"2014","unstructured":"Gallo V, Deneen B (2014) Glial development: the crossroads of regeneration and repair in the CNS. Neuron 83(2):283\u2013308","journal-title":"Neuron"},{"issue":"5","key":"1661_CR62","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/glia.23711","volume":"68","author":"DA Galloway","year":"2020","unstructured":"Galloway DA, Gowing E, Setayeshgar S, Kothary R (2020) Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination. Glia 68(5):859\u2013877","journal-title":"Glia"},{"issue":"1","key":"1661_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12938-021-00857-9","volume":"20","author":"LJ Galv\u00e3o-Lima","year":"2021","unstructured":"Galv\u00e3o-Lima LJ, Morais AH, Valentim RA, Barreto EJ (2021) miRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools. Biomed Eng Online 20(1):21","journal-title":"Biomed Eng Online"},{"issue":"8","key":"1661_CR64","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.autrev.2006.02.012","volume":"5","author":"SA Gauthier","year":"2006","unstructured":"Gauthier SA, Glanz BI, Mandel M, Weiner HL (2006) A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study. Autoimmun Rev 5(8):532\u2013536","journal-title":"Autoimmun Rev"},{"key":"1661_CR65","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.gene.2018.03.035","volume":"659","author":"N Ghadiri","year":"2018","unstructured":"Ghadiri N, Emamnia N, Ganjalikhani-Hakemi M, Ghaedi K, Etemadifar M, Salehi M et al (2018) Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4\u2009+\u2009T lymphocytes of relapsing-remitting multiple sclerosis patients. Gene 659:109\u2013117","journal-title":"Gene"},{"key":"1661_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2022.102194","volume":"63","author":"M Gharagozloo","year":"2022","unstructured":"Gharagozloo M, Bannon R, Calabresi PA (2022) Breaking the barriers to remyelination in multiple sclerosis. Curr Opin Pharmacol 63:102194","journal-title":"Curr Opin Pharmacol"},{"issue":"17","key":"1661_CR67","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3390\/cells13171499","volume":"13","author":"S Gharibi","year":"2024","unstructured":"Gharibi S, Moghimi B, Mahmoudi MB, Shahvazian E, Yazd EF, Yadegari M et al (2024) Dysregulation of miR-223, miR-146a, and miR-193a expression profile in acute and chronic phases of experimental autoimmune encephalomyelitis in C57BL\/6 mice. Cells 13(17):1499","journal-title":"Cells"},{"issue":"6183","key":"1661_CR68","doi-asserted-by":"publisher","first-page":"1252304","DOI":"10.1126\/science.1252304","volume":"344","author":"EM Gibson","year":"2014","unstructured":"Gibson EM, Purger D, Mount CW, Goldstein AK, Lin GL, Wood LS et al (2014) Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science 344(6183):1252304","journal-title":"Science"},{"key":"1661_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103126","volume":"54","author":"A Giuliani","year":"2021","unstructured":"Giuliani A, Lattanzi S, Ramini D, Graciotti L, Danni MC, Procopio AD et al (2021) Potential prognostic value of circulating inflamma-miR-146a-5p and miR-125a-5p in relapsing-remitting multiple sclerosis. Mult Scler Relat Disord 54:103126","journal-title":"Mult Scler Relat Disord"},{"issue":"10111","key":"1661_CR70","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","volume":"390","author":"AJ Green","year":"2017","unstructured":"Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F et al (2017) Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet 390(10111):2481\u20139","journal-title":"Lancet"},{"key":"1661_CR71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fncel.2014.00073","volume":"8","author":"V Gudi","year":"2014","unstructured":"Gudi V, Gingele S, Skripuletz T, Stangel M (2014) Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned. Front Cell Neurosci 8:73","journal-title":"Front Cell Neurosci"},{"issue":"22","key":"1661_CR72","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1212\/WNL.0b013e3182759621","volume":"79","author":"A Haghikia","year":"2012","unstructured":"Haghikia A, Haghikia A, Hellwig K, Baraniskin A, Holzmann A, D\u00e9card BF et al (2012) Regulated MicroRNAs in the CSF of patients with multiple sclerosis: a case-control study. Neurology 79(22):2166\u20132170","journal-title":"Neurology"},{"issue":"3","key":"1661_CR73","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.neuron.2013.11.015","volume":"81","author":"TR Hammond","year":"2014","unstructured":"Hammond TR, Gadea A, Dupree J, Kerninon C, Nait-Oumesmar B, Aguirre A et al (2014) Astrocyte-derived endothelin-1 inhibits remyelination through Notch activation. Neuron 81(3):588\u2013602","journal-title":"Neuron"},{"issue":"3","key":"1661_CR74","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ana.24009","volume":"74","author":"SL Hauser","year":"2013","unstructured":"Hauser SL, Chan JR, Oksenberg JR (2013) Multiple sclerosis: prospects and promise. Ann Neurol 74(3):317\u2013327","journal-title":"Ann Neurol"},{"key":"1661_CR75","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S422114","author":"C He","year":"2023","unstructured":"He C, Li Z, Yang M, Yu W, Luo R, Zhou J et al (2023) Non-coding RNA in microglia activation and neuroinflammation in Alzheimer\u2019s disease. J Inflamm Res. https:\/\/doi.org\/10.2147\/JIR.S422114","journal-title":"J Inflamm Res"},{"issue":"2","key":"1661_CR76","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.neuron.2016.11.044","volume":"93","author":"D He","year":"2017","unstructured":"He D, Wang J, Lu Y, Deng Y, Zhao C, Xu L et al (2017) LncRNA functional networks in oligodendrocytes reveal stage-specific myelination control by an lncOL1\/Suz12 complex in the CNS. Neuron 93(2):362\u2013378","journal-title":"Neuron"},{"issue":"1","key":"1661_CR77","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1096\/fj.11-192716","volume":"26","author":"P He","year":"2012","unstructured":"He P, Liu Q, Wu J, Shen Y (2012) Genetic deletion of TNF receptor suppresses excitatory synaptic transmission via reducing AMPA receptor synaptic localization in cortical neurons. FASEB J 26(1):334","journal-title":"FASEB J"},{"key":"1661_CR78","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20171132","author":"Y He","year":"2018","unstructured":"He Y, Lv B, Huan Y, Liu B, Li Y, Jia L et al (2018) Zhenbao pill protects against acute spinal cord injury via miR-146a-5p regulating the expression of GPR17. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20171132","journal-title":"Biosci Rep"},{"issue":"52","key":"1661_CR79","doi-asserted-by":"publisher","first-page":"27074","DOI":"10.1073\/pnas.1906358116","volume":"116","author":"M Heidari","year":"2019","unstructured":"Heidari M, Radcliff AB, McLellan GJ, Ver Hoeve JN, Chan K, Kiland JA et al (2019) Evoked potentials as a biomarker of remyelination. Proc Natl Acad Sci USA 116(52):27074\u201383","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"1661_CR80","doi-asserted-by":"publisher","first-page":"7167","DOI":"10.3390\/ijms23137167","volume":"23","author":"PT Ho","year":"2022","unstructured":"Ho PT, Clark IM, Le LT (2022) MicroRNA-based diagnosis and therapy. Int J Mol Sci 23(13):7167","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1661_CR81","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.devcel.2013.10.015","volume":"27","author":"LI Hudish","year":"2013","unstructured":"Hudish LI, Blasky AJ, Appel B (2013) miR-219 regulates neural precursor differentiation by direct inhibition of apical par polarity proteins. Dev Cell 27(4):387\u2013398","journal-title":"Dev Cell"},{"issue":"4","key":"1661_CR82","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1089\/sur.2012.126","volume":"13","author":"JM Huston","year":"2012","unstructured":"Huston JM (2012) The vagus nerve and the inflammatory reflex: wandering on a new treatment paradigm for systemic inflammation and sepsis. Surg Infect 13(4):187\u2013193","journal-title":"Surg Infect"},{"key":"1661_CR83","doi-asserted-by":"crossref","unstructured":"Iyer A, Zurolo E, Prabowo A, Fluiter K, Spliet WG, van Rijen PC et al (2012) MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response","DOI":"10.1371\/journal.pone.0044789"},{"issue":"10422","key":"1661_CR84","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","volume":"403","author":"D Jakimovski","year":"2024","unstructured":"Jakimovski D, Bittner S, Zivadinov R, Morrow SA, Benedict RH, Zipp F et al (2024) Multiple sclerosis. Lancet 403(10422):183\u2013202","journal-title":"Lancet"},{"issue":"1","key":"1661_CR85","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrneurol.2010.179","volume":"7","author":"A Junker","year":"2011","unstructured":"Junker A, Hohlfeld R, Meinl E (2011) The emerging role of MicroRNAs in multiple sclerosis. Nat Rev Neurol 7(1):56\u201359","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"1661_CR86","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1093\/brain\/awp300","volume":"132","author":"A Junker","year":"2009","unstructured":"Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R et al (2009) MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 132(12):3342\u20133352","journal-title":"Brain"},{"issue":"7","key":"1661_CR87","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/s41593-022-01097-3","volume":"25","author":"M Kaufmann","year":"2022","unstructured":"Kaufmann M, Schaupp A-L, Sun R, Coscia F, Dendrou CA, Cortes A et al (2022) Identification of early neurodegenerative pathways in progressive multiple sclerosis. Nat Neurosci 25(7):944\u2013955","journal-title":"Nat Neurosci"},{"issue":"13","key":"1661_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134274","volume":"12","author":"Z Khan","year":"2023","unstructured":"Khan Z, Gupta GD, Mehan S (2023) Cellular and molecular evidence of multiple sclerosis diagnosis and treatment challenges. J Clin Med 12(13):4274","journal-title":"J Clin Med"},{"issue":"2","key":"1661_CR89","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s13770-017-0101-y","volume":"15","author":"MJ Kim","year":"2018","unstructured":"Kim MJ, Ryu CH, Kim SM, Lim JY, Kim WS, Jeun S-S (2018) Combined treatment with methylprednisolone and human bone marrow-derived mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis. Tissue Eng Regen Med 15(2):183\u2013194","journal-title":"Tissue Eng Regen Med"},{"issue":"1","key":"1661_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06513-x","volume":"7","author":"SF Kornfeld","year":"2024","unstructured":"Kornfeld SF, Cummings SE, Yaworski R, De Repentigny Y, Gagnon S, Zandee S et al (2024) Loss of miR-145 promotes remyelination and functional recovery in a model of chronic central demyelination. Commun Biol 7(1):813","journal-title":"Commun Biol"},{"issue":"24","key":"1661_CR91","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1212\/WNL.0000000000004716","volume":"89","author":"K Kowalec","year":"2017","unstructured":"Kowalec K, McKay KA, Patten SB, Fisk JD, Evans C, Tremlett H et al (2017) Comorbidity increases the risk of relapse in multiple sclerosis: a prospective study. Neurology 89(24):2455\u20132461","journal-title":"Neurology"},{"issue":"6","key":"1661_CR92","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.1212\/NXI.0000000000000623","volume":"6","author":"S Kramer","year":"2019","unstructured":"Kramer S, Haghikia A, Bang C, Scherf K, Pfanne A, Duscha A et al (2019) Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: a validation study. Neurol Neuroimmunol Neuroinflamm 6(6):e623","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"1661_CR93","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11940-021-00666-4","volume":"23","author":"KM Krysko","year":"2021","unstructured":"Krysko KM, Bove R, Dobson R, Jokubaitis V, Hellwig K (2021) Treatment of women with multiple sclerosis planning pregnancy. Curr Treat Options Neurol 23(4):11","journal-title":"Curr Treat Options Neurol"},{"issue":"1","key":"1661_CR94","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann T, Moccia M, Coetzee T, Cohen JA, Correale J, Graves J et al (2023) Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol 22(1):78\u201388","journal-title":"Lancet Neurol"},{"issue":"7539","key":"1661_CR95","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nature13974","volume":"518","author":"BT Lang","year":"2015","unstructured":"Lang BT, Cregg JM, DePaul MA, Tran AP, Xu K, Dyck SM et al (2015) Modulation of the proteoglycan receptor PTP\u03c3 promotes recovery after spinal cord injury. Nature 518(7539):404\u2013408","journal-title":"Nature"},{"issue":"3","key":"1661_CR96","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028936","volume":"8","author":"H Lassmann","year":"2018","unstructured":"Lassmann H (2018) Multiple sclerosis pathology. Cold Spring Harb Perspect Med 8(3):a028936","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"1661_CR97","doi-asserted-by":"publisher","first-page":"26199","DOI":"10.1038\/srep26199","volume":"6","author":"MJ Lazarczyk","year":"2016","unstructured":"Lazarczyk MJ, Kemmler JE, Eyford BA, Short JA, Varghese M, Sowa A et al (2016) Major histocompatibility complex class I proteins are critical for maintaining neuronal structural complexity in the aging brain. Sci Rep 6(1):26199","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"1661_CR98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jneuroim.2012.02.012","volume":"246","author":"J Lescher","year":"2012","unstructured":"Lescher J, Paap F, Schultz V, Redenbach L, Scheidt U, Rosewich H et al (2012) MicroRNA regulation in experimental autoimmune encephalomyelitis in mice and marmosets resembles regulation in human multiple sclerosis lesions. J Neuroimmunol 246(1\u20132):27\u201333","journal-title":"J Neuroimmunol"},{"key":"1661_CR99","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s12035-011-8231-z","volume":"45","author":"J-S Li","year":"2012","unstructured":"Li J-S, Yao Z-X (2012) MicroRNAs: novel regulators of oligodendrocyte differentiation and potential therapeutic targets in demyelination-related diseases. Mol Neurobiol 45:200\u2013212","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1661_CR100","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10565-022-09761-x","volume":"39","author":"S Li","year":"2023","unstructured":"Li S, Lei Z, Sun T (2023) The role of MicroRNAs in neurodegenerative diseases: a review. Cell Biol Toxicol 39(1):53\u201383","journal-title":"Cell Biol Toxicol"},{"issue":"1","key":"1661_CR101","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000369695","volume":"35","author":"Y Li","year":"2015","unstructured":"Li Y, Du C, Wang W, Ma G, Cui L, Zhou H et al (2015) Genetic association of MiR-146a with multiple sclerosis susceptibility in the Chinese population. Cell Physiol Biochem 35(1):281\u2013291","journal-title":"Cell Physiol Biochem"},{"issue":"7638","key":"1661_CR102","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638):481\u2013487","journal-title":"Nature"},{"issue":"3","key":"1661_CR103","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00204-020-02661-1","volume":"94","author":"Y Ling","year":"2020","unstructured":"Ling Y, Sun L, Wang D, Jiang J, Sun W, Ai W et al (2020) Triclosan induces zebrafish neurotoxicity by abnormal expression of miR-219 targeting oligodendrocyte differentiation of central nervous system. Arch Toxicol 94(3):857\u2013871","journal-title":"Arch Toxicol"},{"issue":"2","key":"1661_CR104","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.artmed.2015.06.004","volume":"65","author":"J Liu","year":"2015","unstructured":"Liu J, Brodley CE, Healy BC, Chitnis T (2015) Removing confounding factors via constraint-based clustering: an application to finding homogeneous groups of multiple sclerosis patients. Artif Intell Med 65(2):79\u201388","journal-title":"Artif Intell Med"},{"key":"1661_CR105","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.conb.2016.06.002","volume":"39","author":"J Liu","year":"2016","unstructured":"Liu J, Moyon S, Hernandez M, Casaccia P (2016) Epigenetic control of oligodendrocyte development: adding new players to old keepers. Curr Opin Neurobiol 39:133\u2013138","journal-title":"Curr Opin Neurobiol"},{"issue":"2","key":"1661_CR106","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/ejn.13485","volume":"45","author":"S Liu","year":"2017","unstructured":"Liu S, Ren C, Qu X, Wu X, Dong F, Chand YK et al (2017) miR-219 attenuates demyelination in cuprizone\u2010induced demyelinated mice by regulating monocarboxylate transporter 1. Eur J Neurosci 45(2):249\u201359","journal-title":"Eur J Neurosci"},{"issue":"1","key":"1661_CR107","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12035-015-9655-7","volume":"54","author":"XS Liu","year":"2017","unstructured":"Liu XS, Chopp M, Pan WL, Wang XL, Fan BY, Zhang Y et al (2017b) MicroRNA-146a promotes oligodendrogenesis in stroke. Mol Neurobiol 54(1):227\u2013237","journal-title":"Mol Neurobiol"},{"key":"1661_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.146422","volume":"1724","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zeng R, Wang Y, Huang W, Hu B, Zhu G et al (2019) Mesenchymal stem cells enhance microglia M2 polarization and attenuate neuroinflammation through TSG-6. Brain Res 1724:146422","journal-title":"Brain Res"},{"issue":"1","key":"1661_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-135","volume":"11","author":"Y Liu","year":"2014","unstructured":"Liu Y, Zhang R, Yan K, Chen F, Huang W, Lv B et al (2014) Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6. J Neuroinflammation 11(1):135","journal-title":"J Neuroinflammation"},{"issue":"8","key":"1661_CR110","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S1474-4422(20)30140-X","volume":"19","author":"C Lubetzki","year":"2020","unstructured":"Lubetzki C, Zalc B, Williams A, Stadelmann C, Stankoff B (2020) Remyelination in multiple sclerosis: from basic science to clinical translation. Lancet Neurol 19(8):678\u2013688","journal-title":"Lancet Neurol"},{"issue":"1","key":"1661_CR111","volume":"6","author":"SQ Ma","year":"2019","unstructured":"Ma SQ, Xu XX, He ZZ, Li XH, Luo JM (2019) Dynamic changes in peripheral blood-targeted miRNA expression profiles in patients with severe traumatic brain injury at high altitude. Mil Med Res 6(1):12","journal-title":"Mil Med Res"},{"issue":"8","key":"1661_CR112","doi-asserted-by":"publisher","first-page":"810","DOI":"10.7150\/ijms.8647","volume":"11","author":"X Ma","year":"2014","unstructured":"Ma X, Zhou J, Zhong Y, Jiang L, Mu P, Li Y et al (2014) Expression, regulation and function of microRNAs in multiple sclerosis. Int J Med Sci 11(8):810\u20138","journal-title":"Int J Med Sci"},{"key":"1661_CR113","doi-asserted-by":"publisher","first-page":"1199313","DOI":"10.3389\/fnmol.2023.1199313","volume":"16","author":"K Maciak","year":"2023","unstructured":"Maciak K, Dziedzic A, Saluk J (2023) Remyelination in multiple sclerosis from the MiRNA perspective. Front Mol Neurosci 16:1199313","journal-title":"Front Mol Neurosci"},{"key":"1661_CR114","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.omtn.2019.10.002","volume":"18","author":"H Mai","year":"2019","unstructured":"Mai H, Fan W, Wang Y, Cai Y, Li X, Chen F et al (2019) Intranasal administration of miR-146a Agomir rescued the pathological process and cognitive impairment in an AD mouse model. Mol Therapy Nucleic Acids 18:681\u2013695","journal-title":"Mol Therapy Nucleic Acids"},{"issue":"3","key":"1661_CR115","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/bph.13674","volume":"174","author":"C Marin-Ba\u00f1asco","year":"2017","unstructured":"Marin-Ba\u00f1asco C, Benabdellah K, Melero\u2010Jerez C, Oliver B, Pinto\u2010Medel MJ, Hurtado\u2010Guerrero I et al (2017) Gene therapy with mesenchymal stem cells expressing IFN\u2010\u00df ameliorates neuroinflammation in experimental models of multiple sclerosis. Br J Pharmacol 174(3):238\u2013253","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1661_CR116","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2174\/1871524922666220929153215","volume":"22","author":"M Marino","year":"2022","unstructured":"Marino M, Mele E, Pastorino GM, Meccariello R, Operto FF, Santoro A et al (2022) Neuroinflammation: molecular mechanisms and therapeutic perspectives. Cent Nerv Syst Agents Med Chem 22(3):160\u201374","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"1661_CR117","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3389\/fimmu.2020.01110","volume":"11","author":"NA Martin","year":"2020","unstructured":"Martin NA, Hyrlov KH, Elkjaer ML, Thygesen EK, Wlodarczyk A, Elbaek KJ et al (2020) Absence of miRNA-146a differentially alters microglia function and proteome. Front Immunol 11:1110","journal-title":"Front Immunol"},{"key":"1661_CR118","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3389\/fimmu.2018.00490","volume":"9","author":"NA Martin","year":"2018","unstructured":"Martin NA, Molnar V, Szilagyi GT, Elkjaer ML, Nawrocki A, Okarmus J et al (2018) Experimental demyelination and axonal loss are reduced in MicroRNA-146a deficient mice. Front Immunol 9:490","journal-title":"Front Immunol"},{"issue":"5","key":"1661_CR119","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nri.2016.40","volume":"16","author":"A Mehta","year":"2016","unstructured":"Mehta A, Baltimore D (2016) MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol 16(5):279\u2013294","journal-title":"Nat Rev Immunol"},{"key":"1661_CR120","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.18246","author":"F Mei","year":"2016","unstructured":"Mei F, Lehmann-Horn K, Shen YA, Rankin KA, Stebbins KJ, Lorrain DS et al (2016) Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery. Elife. https:\/\/doi.org\/10.7554\/eLife.18246","journal-title":"Elife"},{"issue":"6","key":"1661_CR121","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.cell.2012.02.005","volume":"148","author":"JT Mendell","year":"2012","unstructured":"Mendell JT, Olson EN (2012) MicroRNAs in stress signaling and human disease. Cell 148(6):1172\u20131187","journal-title":"Cell"},{"issue":"3","key":"1661_CR122","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s12017-023-08744-3","volume":"25","author":"M Mohammadinasr","year":"2023","unstructured":"Mohammadinasr M, Montazersaheb S, Molavi O, Kahroba H, Talebi M, Ayromlou H et al (2023) Multiplex analysis of cerebrospinal fluid and serum exosomes MicroRNAs of untreated relapsing remitting multiple sclerosis (RRMS) and proposing noninvasive diagnostic biomarkers. Neuromol Med 25(3):402\u2013414","journal-title":"Neuromol Med"},{"issue":"3","key":"1661_CR123","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1606468","volume":"376","author":"X Montalban","year":"2017","unstructured":"Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G et al (2017) Ocrelizumab versus placebo in primary progressive multiple sclerosis. N Engl J Med 376(3):209\u2013220","journal-title":"N Engl J Med"},{"key":"1661_CR124","doi-asserted-by":"publisher","first-page":"117793222211163","DOI":"10.1177\/11779322221116322","volume":"16","author":"M Moraghebi","year":"2022","unstructured":"Moraghebi M, Negahi AA, Bazireh H, Abbasi H, Ahmadi M, Sarikhani Z et al (2022) The analysis of snps\u2019 function in miR-21 and miR146a\/b in multiple sclerosis and active lesions: an in silico study. Bioinform Biol Insights 16:11779322221116322","journal-title":"Bioinform Biol Insights"},{"key":"1661_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00916","volume":"13","author":"K Morimoto","year":"2019","unstructured":"Morimoto K, Nakajima K (2019) Role of the immune system in the development of the central nervous system. Front Neurosci 13:916","journal-title":"Front Neurosci"},{"issue":"10","key":"1661_CR126","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1093\/brain\/awz245","volume":"142","author":"B Morquette","year":"2019","unstructured":"Morquette B, Ju\u017awik CA, Drake SS, Charabati M, Zhang Y, L\u00e9cuyer M-A et al (2019) MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis. Brain 142(10):2979\u20132995","journal-title":"Brain"},{"issue":"12","key":"1661_CR127","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.tcb.2013.07.007","volume":"23","author":"BM Morrison","year":"2013","unstructured":"Morrison BM, Lee Y, Rothstein JD (2013) Oligodendroglia: metabolic supporters of axons. Trends Cell Biol 23(12):644\u2013651","journal-title":"Trends Cell Biol"},{"issue":"8","key":"1661_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083889","volume":"26","author":"O Mosora","year":"2025","unstructured":"Mosora O, Maier S, Manu D, B\u0103rcu\u021bean L, Roman M, Dumitreas\u0103 M et al (2025) Exosomal microRNAs as early transition biomarkers from recurrent-remissive to secondary progressive multiple sclerosis. Int J Mol Sci 26(8):3889","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1661_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1590-5","volume":"16","author":"M Mu\u00f1oz-San Mart\u00edn","year":"2019","unstructured":"Mu\u00f1oz-San Mart\u00edn M, Reverter G, Robles-Cede\u00f1o R, Bux\u00f2 M, Ortega FJ, G\u00f3mez I et al (2019) Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a\/b in patients with multiple sclerosis and active lesions. J Neuroinflammation 16(1):220","journal-title":"J Neuroinflammation"},{"key":"1661_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1590-5","volume":"16","author":"M Mu\u00f1oz-San Mart\u00edn","year":"2019","unstructured":"Mu\u00f1oz-San Mart\u00edn M, Reverter G, Robles-Cede\u00f1o R, Bux\u00f2 M, Ortega FJ, G\u00f3mez I et al (2019a) Analysis of MiRNA signatures in CSF identifies upregulation of miR-21 and miR-146a\/b in patients with multiple sclerosis and active lesions. J Neuroinflamm 16:1\u201310","journal-title":"J Neuroinflamm"},{"issue":"6\u20137","key":"1661_CR131","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/jgm.2717","volume":"15","author":"T Nata","year":"2013","unstructured":"Nata T, Fujiya M, Ueno N, Moriichi K, Konishi H, Tanabe H et al (2013) MicroRNA-146b improves intestinal injury in mouse colitis by activating nuclear factor\u2010\u03baB and improving epithelial barrier function. J Gene Med 15(6\u20137):249\u201360","journal-title":"J Gene Med"},{"issue":"1","key":"1661_CR132","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-cellbio-100913-013101","volume":"30","author":"K-A Nave","year":"2014","unstructured":"Nave K-A, Werner HB (2014) Myelination of the nervous system: mechanisms and functions. Annu Rev Cell Dev Biol 30(1):503\u2013533","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1661_CR133","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jchemneu.2018.03.001","volume":"91","author":"B Nazari","year":"2018","unstructured":"Nazari B, Soleimani M, Ebrahimi-Barough S, Enderami SE, Kazemi M, Negahdari B et al (2018) Overexpression of miR-219 promotes differentiation of human induced pluripotent stem cells into pre-oligodendrocyte. J Chem Neuroanat 91:8\u201316","journal-title":"J Chem Neuroanat"},{"issue":"4","key":"1661_CR134","doi-asserted-by":"publisher","first-page":"739","DOI":"10.4103\/1673-5374.266922","volume":"15","author":"LH Nguyen","year":"2020","unstructured":"Nguyen LH, Ong W, Wang K, Wang M, Nizetic D, Chew SY (2020) Effects of miR-219\/miR-338 on microglia and astrocyte behaviors and astrocyte-oligodendrocyte precursor cell interactions. Neural Regen Res 15(4):739\u2013747","journal-title":"Neural Regen Res"},{"issue":"17 Suppl","key":"1661_CR135","first-page":"s321","volume":"19","author":"K Noyes","year":"2013","unstructured":"Noyes K, Weinstock-Guttman B (2013) Impact of diagnosis and early treatment on the course of multiple sclerosis. Am J Manag Care 19(17 Suppl):s321\u2013s331","journal-title":"Am J Manag Care"},{"key":"1661_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O'Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol 9:402","journal-title":"Front Endocrinol"},{"issue":"2","key":"1661_CR137","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/pharmaceutics12020186","volume":"12","author":"I Osorio-Querejeta","year":"2020","unstructured":"Osorio-Querejeta I, Carregal-Romero S, Ayerdi-Izquierdo A, M\u00e4ger I, Nash LA, Wood M et al (2020) MiR-219a-5p enriched extracellular vesicles induce OPC differentiation and EAE improvement more efficiently than liposomes and polymeric nanoparticles. Pharmaceutics 12(2):186","journal-title":"Pharmaceutics"},{"issue":"7","key":"1661_CR138","doi-asserted-by":"publisher","first-page":"e6309","DOI":"10.1371\/journal.pone.0006309","volume":"4","author":"D Otaegui","year":"2009","unstructured":"Otaegui D, Baranzini SE, Arma\u00f1anzas R, Calvo B, Mu\u00f1oz-Culla M, Khankhanian P et al (2009) Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS ONE 4(7):e6309","journal-title":"PLoS ONE"},{"issue":"11","key":"1661_CR139","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13111586","volume":"13","author":"M Pagoni","year":"2023","unstructured":"Pagoni M, Cava C, Sideris DC, Avgeris M, Zoumpourlis V, Michalopoulos I et al (2023) miRNA-based technologies in cancer therapy. J Pers Med 13(11):1586","journal-title":"J Pers Med"},{"key":"1661_CR140","doi-asserted-by":"crossref","unstructured":"Pan Y, Jia T, Zhang Y, Zhang K, Zhang R, Li J et al (2012) MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice. Int J Nanomed. :5957\u20135967","DOI":"10.2147\/IJN.S37990"},{"issue":"4","key":"1661_CR141","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1152\/physiolgenomics.00133.2016","volume":"49","author":"MR Paterson","year":"2017","unstructured":"Paterson MR, Kriegel AJ (2017) MiR-146a\/b: a family with shared seeds and different roots. Physiol Genomics 49(4):243\u2013252","journal-title":"Physiol Genomics"},{"issue":"23","key":"1661_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252312637","volume":"25","author":"O Perdaens","year":"2024","unstructured":"Perdaens O, van Pesch V (2024) Should we consider neurodegeneration by itself or in a triangulation with neuroinflammation and demyelination? The example of multiple sclerosis and beyond. Int J Mol Sci 25(23):12637","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1661_CR143","first-page":"e200025","volume":"9","author":"D Pitt","year":"2022","unstructured":"Pitt D, Lo CH, Gauthier SA, Hickman RA, Longbrake E, Airas LM et al (2022) Toward precision phenotyping of multiple sclerosis. Neurology: Neuroimmunol Neuroinflammation 9(6):e200025","journal-title":"Neurology: Neuroimmunol Neuroinflammation"},{"issue":"17","key":"1661_CR144","doi-asserted-by":"publisher","first-page":"9198","DOI":"10.3390\/ijms22179198","volume":"22","author":"AI Pogue","year":"2021","unstructured":"Pogue AI, Lukiw WJ (2021) microRNA-146a-5p, neurotropic viral infection and prion disease (PrD). Int J Mol Sci 22(17):9198","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1661_CR145","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.4049\/jimmunol.1103096","volume":"188","author":"C Prado","year":"2012","unstructured":"Prado C, Contreras F, Gonz\u00e1lez H, D\u00edaz P, Elgueta D, Barrientos M et al (2012) Stimulation of Dopamine Receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity. J Immunol 188(7):3062\u201370","journal-title":"J Immunol"},{"issue":"3","key":"1661_CR146","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3390\/ijms22031176","volume":"22","author":"F Precazzini","year":"2021","unstructured":"Precazzini F, Detassis S, Imperatori AS, Denti MA, Campomenosi P (2021) Measurements methods for the development of MicroRNA-based tests for cancer diagnosis. Int J Mol Sci 22(3):1176","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1661_CR147","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/glia.22606","volume":"62","author":"AD Pusic","year":"2014","unstructured":"Pusic AD, Kraig RP (2014) Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination. Glia 62(2):284\u2013299","journal-title":"Glia"},{"issue":"10","key":"1661_CR148","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1089\/jir.2015.0010","volume":"35","author":"AD Pusic","year":"2015","unstructured":"Pusic AD, Kraig RP (2015) Phasic treatment with interferon gamma stimulates release of exosomes that protect against spreading depression. J Interferon Cytokine Res 35(10):795\u2013807","journal-title":"J Interferon Cytokine Res"},{"issue":"1\u20132","key":"1661_CR149","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jneuroim.2013.10.014","volume":"266","author":"AD Pusic","year":"2014","unstructured":"Pusic AD, Pusic KM, Clayton BL, Kraig RP (2014) IFN\u03b3-stimulated dendritic cell exosomes as a potential therapeutic for remyelination. J Neuroimmunol 266(1\u20132):12\u201323","journal-title":"J Neuroimmunol"},{"key":"1661_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.01330","volume":"10","author":"A Quillet","year":"2020","unstructured":"Quillet A, Saad C, Ferry G, Anouar Y, Vergne N, Lecroq T et al (2020) Improving bioinformatics prediction of microRNA targets by ranks aggregation. Front Genet 10:1330","journal-title":"Front Genet"},{"issue":"13","key":"1661_CR151","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1177\/1352458516684213","volume":"23","author":"E Quintana","year":"2017","unstructured":"Quintana E, Ortega FJ, Robles-Cede\u00f1o R, Villar ML, Bux\u00f3 M, Mercader JM et al (2017) miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands. Mult Scler J 23(13):1716\u201326","journal-title":"Mult Scler J"},{"issue":"17","key":"1661_CR152","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1212\/WNL.0000000000005347","volume":"90","author":"A Rae-Grant","year":"2018","unstructured":"Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS et al (2018) Practice guideline recommendations summary: disease-modifying therapies for adults with multiple sclerosis: report of the guideline Development, Dissemination, and implementation subcommittee of the American academy of neurology. Neurology 90(17):777\u2013788","journal-title":"Neurology"},{"issue":"12","key":"1661_CR153","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1523\/JNEUROSCI.1530-18.2019","volume":"39","author":"KA Rankin","year":"2019","unstructured":"Rankin KA, Mei F, Kim K, Shen Y-AA, Mayoral SR, Desponts C et al (2019) Selective estrogen receptor modulators enhance CNS remyelination independent of estrogen receptors. J Neurosci 39(12):2184\u201394","journal-title":"J Neurosci"},{"issue":"12","key":"1661_CR154","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/jnen\/nlz098","volume":"78","author":"VT Rao","year":"2019","unstructured":"Rao VT, Fuh S-C, Karamchandani JR, Woulfe JM, Munoz DG, Ellezam B et al (2019) Astrocytes in the pathogenesis of multiple sclerosis: an in situ microRNA study. J Neuropathol Exp Neurol 78(12):1130\u201346","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"1661_CR155","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41583-020-00406-8","volume":"22","author":"MN Rasband","year":"2021","unstructured":"Rasband MN, Peles E (2021) Mechanisms of node of Ranvier assembly. Nat Rev Neurosci 22(1):7\u201320","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"1661_CR156","doi-asserted-by":"publisher","DOI":"10.1177\/2055217317700668","volume":"3","author":"VM Rivera","year":"2017","unstructured":"Rivera VM, Macias MA (2017) Access and barriers to MS care in Latin America. Multiple Sclerosis Journal\u2013Experimental, Translational and Clinical 3(1):2055217317700668","journal-title":"Multiple Sclerosis Journal\u2013Experimental, Translational and Clinical"},{"key":"1661_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103176","volume":"55","author":"R Rodrigues","year":"2021","unstructured":"Rodrigues R, Rocha R, Bonif\u00e1cio G, Ferro D, Saben\u00e7a F, Gon\u00e7alves AI et al (2021) Therapeutic inertia in relapsing-remitting multiple sclerosis. Mult Scler Relat Disord 55:103176","journal-title":"Mult Scler Relat Disord"},{"key":"1661_CR158","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fimmu.2019.00043","volume":"10","author":"M Romano","year":"2019","unstructured":"Romano M, Fanelli G, Albany CJ, Giganti G, Lombardi G (2019) Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity. Front Immunol 10:43","journal-title":"Front Immunol"},{"issue":"5","key":"1661_CR159","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1177\/1756285613484079","volume":"6","author":"\u00c0 Rovira","year":"2013","unstructured":"Rovira \u00c0, Auger C, Alonso J (2013) Magnetic resonance monitoring of lesion evolution in multiple sclerosis. Ther Adv Neurol Disord 6(5):298\u2013310","journal-title":"Ther Adv Neurol Disord"},{"issue":"12","key":"1661_CR160","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1523\/JNEUROSCI.5859-10.2011","volume":"31","author":"JK Sabo","year":"2011","unstructured":"Sabo JK, Aumann TD, Merlo D, Kilpatrick TJ, Cate HS (2011) Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions. J Neurosci 31(12):4504\u20134510","journal-title":"J Neurosci"},{"issue":"8","key":"1661_CR161","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082448","volume":"19","author":"M S\u00e1enz-Cuesta","year":"2018","unstructured":"S\u00e1enz-Cuesta M, Alberro A, Mu\u00f1oz-Culla M, Osorio-Querejeta I, Fernandez-Mercado M, Lopetegui I et al (2018) The first dose of fingolimod affects circulating extracellular vesicles in multiple sclerosis patients. Int J Mol Sci 19(8):2448","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1661_CR162","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.neuron.2017.11.026","volume":"96","author":"C Sampaio-Baptista","year":"2017","unstructured":"Sampaio-Baptista C, Johansen-Berg H (2017) White matter plasticity in the adult brain. Neuron 96(6):1239\u20131251","journal-title":"Neuron"},{"key":"1661_CR163","doi-asserted-by":"publisher","first-page":"637829","DOI":"10.3389\/fimmu.2021.637829","volume":"12","author":"C Schinocca","year":"2021","unstructured":"Schinocca C, Rizzo C, Fasano S, Grasso G, La Barbera L, Ciccia F et al (2021) Role of the IL-23\/IL-17 pathway in rheumatic diseases: an overview. Front Immunol 12:637829","journal-title":"Front Immunol"},{"issue":"4","key":"1661_CR164","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/practneurol-2015-001139","volume":"15","author":"N Scolding","year":"2015","unstructured":"Scolding N, Barnes D, Cader S, Chataway J, Chaudhuri A, Coles A et al (2015) Association of British neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis. Pract Neurol 15(4):273\u2013279","journal-title":"Pract Neurol"},{"issue":"5","key":"1661_CR165","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/ana.24931","volume":"81","author":"I Selmaj","year":"2017","unstructured":"Selmaj I, Cichalewska M, Namiecinska M, Galazka G, Horzelski W, Selmaj KW et al (2017) Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Ann Neurol 81(5):703\u201317","journal-title":"Ann Neurol"},{"issue":"1","key":"1661_CR166","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00415-023-11969-8","volume":"271","author":"K Selmaj","year":"2024","unstructured":"Selmaj K, Cree BAC, Barnett M, Thompson A, Hartung HP (2024) Multiple sclerosis: time for early treatment with high-efficacy drugs. J Neurol 271(1):105\u2013115","journal-title":"J Neurol"},{"issue":"6","key":"1661_CR167","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4103\/RPS.RPS_163_23","volume":"19","author":"N Shamaeizadeh","year":"2024","unstructured":"Shamaeizadeh N, Mirian M (2024) MicroRNA-219 in the central nervous system: a potential theranostic approach. Res Pharm Sci 19(6):634\u2013655","journal-title":"Res Pharm Sci"},{"issue":"10","key":"1661_CR168","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.4161\/rna.21998","volume":"9","author":"J Shu","year":"2012","unstructured":"Shu J, Xia Z, Li L, Liang ET, Slipek N, Shen D et al (2012) Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs. RNA Biol 9(10):1275\u201387","journal-title":"RNA Biol"},{"key":"1661_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.crtox.2025.100229","volume":"8","author":"BB Silver","year":"2025","unstructured":"Silver BB, Fannin R, Gerrish K, Tokar EJ (2025) Characterization of extracellular vesicles and miRNA released by cerebral organoids. Curr Res Toxicol 8:100229","journal-title":"Curr Res Toxicol"},{"issue":"13","key":"1661_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133702","volume":"11","author":"CA Sirbu","year":"2022","unstructured":"Sirbu CA, Ivan R, Vasile TM, Eftimie LG, Costache DO (2022) Cutaneous adverse reactions associated with monoclonal antibodies treatment in multiple sclerosis: case reports and short literature review. J Clin Med 11(13):3702","journal-title":"J Clin Med"},{"issue":"2","key":"1661_CR171","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna5020035","volume":"5","author":"JA Slota","year":"2019","unstructured":"Slota JA, Booth SA (2019) MicroRNAs in neuroinflammation: implications in disease pathogenesis, biomarker discovery and therapeutic applications. Non-coding RNA 5(2):35","journal-title":"Non-coding RNA"},{"issue":"7","key":"1661_CR172","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/dneu.22849","volume":"81","author":"E Sock","year":"2021","unstructured":"Sock E, Wegner M (2021) Using the lineage determinants Olig2 and Sox10 to explore transcriptional regulation of oligodendrocyte development. Dev Neurobiol 81(7):892\u2013901","journal-title":"Dev Neurobiol"},{"issue":"2","key":"1661_CR173","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40120-019-0139-y","volume":"8","author":"J Steinberg","year":"2019","unstructured":"Steinberg J, Fragoso YD, Duran Quiroz JC, Garc\u00eda JR, Guerra C, Rodriguez V et al (2019) Practical issues concerning the approval and use of biosimilar drugs for the treatment of multiple sclerosis in Latin America. Neurol Ther 8(2):207\u201314","journal-title":"Neurol Ther"},{"key":"1661_CR174","doi-asserted-by":"crossref","unstructured":"Stys PK, Tsutsui S (2019) Recent advances in Understanding multiple sclerosis. F1000Research. ;8:F1000 Faculty Rev-2100.","DOI":"10.12688\/f1000research.20906.1"},{"issue":"13","key":"1661_CR175","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136765","volume":"22","author":"I Suster","year":"2021","unstructured":"Suster I, Feng Y (2021) Multifaceted regulation of MicroRNA biogenesis: essential roles and functional integration in neuronal and glial development. Int J Mol Sci 22(13):6765","journal-title":"Int J Mol Sci"},{"key":"1661_CR176","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3389\/fimmu.2018.01377","volume":"9","author":"A Tahamtan","year":"2018","unstructured":"Tahamtan A, Teymoori-Rad M, Nakstad B, Salimi V (2018) Anti-inflammatory MicroRNAs and their potential for inflammatory diseases treatment. Front Immunol 9:1377","journal-title":"Front Immunol"},{"issue":"1","key":"1661_CR177","first-page":"6512620","volume":"2017","author":"H Tao","year":"2017","unstructured":"Tao H, Zhao J, Liu T, Cai Y, Zhou X, Xing H et al (2017) Intranasal delivery of miR-146a mimics delayed seizure onset in the lithium\u2010pilocarpine mouse model. Mediat Inflamm 2017(1):6512620","journal-title":"Mediat Inflamm"},{"issue":"12","key":"1661_CR178","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1093\/brain\/awac307","volume":"145","author":"V Tepav\u010devi\u0107","year":"2022","unstructured":"Tepav\u010devi\u0107 V, Lubetzki C (2022) Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier? Brain 145(12):4178\u20134192","journal-title":"Brain"},{"issue":"2","key":"1661_CR179","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u201373","journal-title":"Lancet Neurol"},{"issue":"10","key":"1661_CR180","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/cells8101236","volume":"8","author":"A Tiane","year":"2019","unstructured":"Tiane A, Schepers M, Rombaut B, Hupperts R, Prickaerts J, Hellings N et al (2019) From OPC to oligodendrocyte: an epigenetic journey. Cells 8(10):1236","journal-title":"Cells"},{"issue":"5","key":"1661_CR181","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/acn3.750","volume":"6","author":"A Tripathi","year":"2019","unstructured":"Tripathi A, Volsko C, Datta U, Regev K, Dutta R (2019) Expression of disease-related Mi RNA s in white\u2010matter lesions of progressive multiple sclerosis brains. Ann Clin Transl Neurol 6(5):854\u2013862","journal-title":"Ann Clin Transl Neurol"},{"key":"1661_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117202","volume":"420","author":"AV Varma-Doyle","year":"2021","unstructured":"Varma-Doyle AV, Lukiw WJ, Zhao Y, Lovera J, Devier D (2021) A hypothesis-generating scoping review of miRs identified in both multiple sclerosis and dementia, their protein targets, and miR signaling pathways. J Neurol Sci 420:117202","journal-title":"J Neurol Sci"},{"issue":"14","key":"1661_CR183","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA et al (2020) Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS. Multiple Scler J 26(14):1816\u20131821","journal-title":"Multiple Scler J"},{"issue":"6","key":"1661_CR184","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.devcel.2017.03.001","volume":"40","author":"H Wang","year":"2017","unstructured":"Wang H, Moyano AL, Ma Z, Deng Y, Lin Y, Zhao C et al (2017a) miR-219 cooperates with miR-338 in Myelination and promotes Myelin repair in the CNS. Dev Cell 40(6):566\u2013582 e5","journal-title":"Dev Cell"},{"issue":"4","key":"1661_CR185","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/jnc.15728","volume":"164","author":"JQ Wang","year":"2023","unstructured":"Wang JQ, Gao MY, Gao R, Zhao KH, Zhang Y, Li X (2023) Oligodendrocyte lineage cells: advances in development, disease, and heterogeneity. J Neurochem 164(4):468\u2013480","journal-title":"J Neurochem"},{"key":"1661_CR186","doi-asserted-by":"crossref","unstructured":"Wang K, Yuan Y, Cho J-H, McClarty S, Baxter D, Galas DJ (2012) Comparing the MicroRNA spectrum between serum and plasma","DOI":"10.1371\/journal.pone.0041561"},{"issue":"1","key":"1661_CR187","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19703-5","volume":"8","author":"Y-L Wang","year":"2018","unstructured":"Wang Y-L, Xue P, Xu C-Y, Wang Z, Liu X-S, Hua L-L et al (2018) SPK1-transfected UCMSC has better therapeutic activity than UCMSC in the treatment of experimental autoimmune encephalomyelitis model of multiple sclerosis. Sci Rep 8(1):1756","journal-title":"Sci Rep"},{"issue":"1","key":"1661_CR188","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-7-S1-S1","volume":"7","author":"R Warrington","year":"2011","unstructured":"Warrington R, Watson W, Kim HL, Antonetti FR (2011) An introduction to immunology and immunopathology. Allergy Asthma Clin Immunol 7(1):S1","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"Pt B","key":"1661_CR189","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.expneurol.2016.03.019","volume":"283","author":"NA Wheeler","year":"2016","unstructured":"Wheeler NA, Fuss B (2016) Extracellular cues influencing oligodendrocyte differentiation and (re)myelination. Exp Neurol 283(Pt B):512\u2013530","journal-title":"Exp Neurol"},{"key":"1661_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102015","volume":"41","author":"L Wooliscroft","year":"2020","unstructured":"Wooliscroft L, Altowaijri G, Hildebrand A, Samuels M, Oken B, Bourdette D et al (2020) Phase I randomized trial of liothyronine for remyelination in multiple sclerosis: a dose-ranging study with assessment of reliability of visual outcomes. Mult Scler Relat Disord 41:102015","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"1661_CR191","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/jcbfm.2014.207","volume":"35","author":"D Wu","year":"2015","unstructured":"Wu D, Cerutti C, Lopez-Ramirez MA, Pryce G, King-Robson J, Simpson JE et al (2015) Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-\u03baB activation. J Cereb Blood Flow Metabolism 35(3):412\u2013423","journal-title":"J Cereb Blood Flow Metabolism"},{"issue":"1","key":"1661_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y (2023) The blood\u2013brain barrier: structure, regulation and drug delivery. Signal Transduct Target Ther 8(1):217","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"1661_CR193","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.imlet.2012.09.004","volume":"148","author":"P Xia","year":"2012","unstructured":"Xia P, Fang X, Zhang Z-h, Huang Q, Yan K-x, Kang K-f et al (2012) Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions. Immunol Lett 148(2):151\u2013162","journal-title":"Immunol Lett"},{"issue":"8","key":"1661_CR194","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/dneu.22856","volume":"81","author":"W Xia","year":"2021","unstructured":"Xia W, Fancy SP (2021) Mechanisms of oligodendrocyte progenitor developmental migration. Dev Neurobiol 81(8):985\u2013996","journal-title":"Dev Neurobiol"},{"issue":"1","key":"1661_CR195","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02165-4","volume":"18","author":"B Yang","year":"2021","unstructured":"Yang B, Yang R, Xu B, Fu J, Qu X, Li L et al (2021) miR-155 and miR-146a collectively regulate meningitic Escherichia coli infection-mediated neuroinflammatory responses. J Neuroinflammation 18(1):114","journal-title":"J Neuroinflammation"},{"issue":"9","key":"1661_CR196","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1084\/jem.20112218","volume":"209","author":"L Yang","year":"2012","unstructured":"Yang L, Boldin MP, Yu Y, Liu CS, Ea C-K, Ramakrishnan P et al (2012) miR-146a controls the resolution of T cell responses in mice. J Exp Med 209(9):1655\u201370","journal-title":"J Exp Med"},{"key":"1661_CR197","doi-asserted-by":"crossref","unstructured":"Yang Q, Lai SK (2017) Engineering well-characterized PEG-coated nanoparticles for elucidating biological barriers to drug delivery. Cancer Nanotechnology: Methods and Protocols: Springer; pp. 125\u2009\u2013\u200937","DOI":"10.1007\/978-1-4939-6646-2_8"},{"issue":"1","key":"1661_CR198","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12974-023-02856-0","volume":"20","author":"R Yang","year":"2023","unstructured":"Yang R, Yang B, Liu W, Tan C, Chen H, Wang X (2023) Emerging role of non-coding RNAs in neuroinflammation mediated by microglia and astrocytes. J Neuroinflamm 20(1):173","journal-title":"J Neuroinflamm"},{"key":"1661_CR199","doi-asserted-by":"publisher","first-page":"1441733","DOI":"10.3389\/fimmu.2024.1441733","volume":"15","author":"A Zabalza","year":"2024","unstructured":"Zabalza A, Pappolla A, Comabella M, Montalban X, Malhotra S (2024) MiRNA-based therapeutic potential in multiple sclerosis. Front Immunol 15:1441733","journal-title":"Front Immunol"},{"issue":"6","key":"1661_CR200","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.stem.2010.04.002","volume":"6","author":"M Zawadzka","year":"2010","unstructured":"Zawadzka M, Rivers LE, Fancy SP, Zhao C, Tripathi R, Jamen F et al (2010) CNS-resident glial progenitor\/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 6(6):578\u201390","journal-title":"Cell Stem Cell"},{"key":"1661_CR201","doi-asserted-by":"publisher","first-page":"1238930","DOI":"10.3389\/fimmu.2023.1238930","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang J, Li A, Gu R, Tong Y, Cheng J (2023) Role and regulatory mechanism of MicroRNA mediated neuroinflammation in neuronal system diseases. Front Immunol 14:1238930","journal-title":"Front Immunol"},{"key":"1661_CR202","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuroscience.2017.02.029","volume":"348","author":"J Zhang","year":"2017","unstructured":"Zhang J, Zhang ZG, Lu M, Wang X, Shang X, Elias SB et al (2017) MiR-146a promotes remyelination in a Cuprizone model of demyelinating injury. Neuroscience 348:252\u2013263","journal-title":"Neuroscience"},{"key":"1661_CR203","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.nbd.2019.01.019","volume":"125","author":"J Zhang","year":"2019","unstructured":"Zhang J, Zhang ZG, Lu M, Zhang Y, Shang X, Chopp M (2019) MiR-146a promotes oligodendrocyte progenitor cell differentiation and enhances remyelination in a model of experimental autoimmune encephalomyelitis. Neurobiol Dis 125:154\u2013162","journal-title":"Neurobiol Dis"},{"issue":"5","key":"1661_CR204","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.neuron.2010.02.018","volume":"65","author":"X Zhao","year":"2010","unstructured":"Zhao X, He X, Han X, Yu Y, Ye F, Chen Y et al (2010) Microrna-mediated control of oligodendrocyte differentiation. Neuron 65(5):612\u2013626","journal-title":"Neuron"},{"issue":"7","key":"1661_CR205","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/aps.2018.30","volume":"39","author":"S-s Zhou","year":"2018","unstructured":"Zhou S-s, Jin J-p, Wang J-q, Zhang Z-g, Freedman JH, Zheng Y et al (2018) Mirnas in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacol Sin 39(7):1073\u201384","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"1661_CR206","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1007\/s11064-020-03009-y","volume":"45","author":"X Zhou","year":"2020","unstructured":"Zhou X, Liu X, Liu L, Han C, Xie Z, Liu X et al (2020) Transplantation of IFN-\u03b3 primed hUCMSCs significantly improved outcomes of experimental autoimmune encephalomyelitis in a mouse model. Neurochem Res 45(7):1510\u20131517","journal-title":"Neurochem Res"},{"issue":"Pt A","key":"1661_CR207","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.brainres.2016.07.034","volume":"1648","author":"X Zhou","year":"2016","unstructured":"Zhou X, Su S, Li S, Pang X, Chen C, Li J et al (2016) MicroRNA-146a down-regulation correlates with neuroprotection and targets pro-apoptotic genes in cerebral ischemic injury in vitro. Brain Res 1648(Pt A):136\u2013143","journal-title":"Brain Res"},{"issue":"1","key":"1661_CR208","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13024-024-00742-8","volume":"19","author":"O Zveik","year":"2024","unstructured":"Zveik O, Rechtman A, Ganz T, Vaknin-Dembinsky A (2024) The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells. Mol Neurodegener 19(1):53","journal-title":"Mol Neurodegener"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-025-01661-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01661-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01661-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:05:23Z","timestamp":1769508323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-025-01661-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":208,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1661"],"URL":"https:\/\/doi.org\/10.1007\/s10571-025-01661-y","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"1 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Ethical approval for this study was obtained from Saveh University of Medical Sciences Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"22"}}